awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q26859114-D5DF9966-D0D2-4E99-8439-F6B1340788A7
Q26859114-D5DF9966-D0D2-4E99-8439-F6B1340788A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26859114-D5DF9966-D0D2-4E99-8439-F6B1340788A7
Emerging therapeutic strategies for Epstein-Barr virus+ post-transplant lymphoproliferative disorder
P2860
Q26859114-D5DF9966-D0D2-4E99-8439-F6B1340788A7
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26859114-D5DF9966-D0D2-4E99-8439-F6B1340788A7
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
cf5a0d9adb7cb020584b421016f57abcc3e49475
P2860
The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Eμ- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling.